25 Mar 2024 Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy Member news
28 Feb 2024 DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase Member news
21 Feb 2024 Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia Member news
23 Jan 2024 Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure Member news
16 Jan 2024 KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy Member news
20 Dec 2023 argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus Member news
20 Dec 2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301 Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
